Home

JEREMY CURNOCK COOK

CIK 1216486 · Chairman of the Board · last filed 2026-06-04

JEREMY CURNOCK COOK is a Chairman of the Board who has filed 30 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for RCEL, was dated Jun 4, 2026. Across all open-market trades the lifetime net is +$1.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $379.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$379.1K

Companies

4

Total Filings

30

Lifetime Open-Market Net

$1.05M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RCEL Director 62,050 $4.61 $286.1K -$62.1K 8 2026-06-04
ARMP Director — $4.73 — $0 1 2019-05-24
Armata Pharmaceuticals, Inc. (APHB) Delisted Director 5,156 — — $1.11M 4 2018-03-26
TGEN Chairman of the Board 30,000 $3.10 $93.0K $0 3 2009-06-02

Recent Filings

30 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-04 RCEL Grant (A) +22,214 $0 EDGAR
2025-06-05 RCEL Grant (A) +10,022 $0 EDGAR
2024-06-06 RCEL Grant (A) +9,200 $0 EDGAR
2023-12-22 RCEL Sell (S) −2,500 -$31.2K EDGAR
2023-12-14 RCEL Sell (S) −2,518 -$30.9K EDGAR
2023-06-08 RCEL Grant (A) +6,175 $0 EDGAR
2022-12-14 RCEL Grant (A) +12,589 $0 EDGAR
2021-12-27 RCEL Grant (A) +4,350 $0 EDGAR
2019-05-24 ARMP Grant (A) — $0 EDGAR
2018-03-26 Armata Pharmaceuticals, Inc. (APHB) Delisted Buy (P) +354,315 $545.3K EDGAR
Showing 1–10 of 30
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.